Churchill Capital Corp VII

    Churchill Capital Corp VII

    NNYSE:CVII
    9.99
    USD
    0.00
    (0.00%)
    45,217.09P/E
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    TTM
    Revenue per Share
    - -
    - -
    - -
    - -
    - -
    Basic EPS, GAAP
    - -
    -0.03
    0.41
    0.13
    - -
    Free Cash Flow per Basic Share
    - -
    -0.02
    -0.01
    -0.15
    -0.2
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    - -
    8.3
    7.81
    4.47
    5.94
    Tangible Book Value per Share
    - -
    8.3
    7.81
    4.65
    6.01
    Basic Weighted Avg Shares
    - -
    154
    173
    122
    92
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    Depreciation Expense
    - -
    - -
    - -
    - -
    - -
    Net Income, GAAP
    - -
    -4
    71
    16
    - -
    Effective Tax Rate (%)
    - -
    - -
    5.54
    44.24
    99.83
    Profit Margin (%)
    - -
    - -
    - -
    - -
    - -
    Working Capital
    - -
    5
    1
    -17
    -26
    LT Debt
    - -
    - -
    - -
    - -
    - -
    Total Equity
    - -
    1,277
    1,348
    569
    553
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    5.42
    1.72
    - -
    Return on Common Equity (%)
    - -
    -0.68
    5.42
    1.73
    - -

    Capital Structure

    USD

    •

    in mil. unless spec.
    Dec'23
    Mar'24
    Jun'24
    ST Debt
    8
    11
    15
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    93
    92
    92
    Market Capitalization
    1,394
    1,134
    991

    Working Capital

    USD

    •

    in mil. unless spec.
    Dec'23
    Mar'24
    Jun'24
    Total Current Assets
    5
    1
    - -
    Cash, Cash Equivalents & STI
    5
    1
    - -
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    22
    24
    26
    Payables & Accruals
    14
    13
    11
    ST Debt
    8
    11
    15
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    - -
    -57.75%
    Free Cash Flow
    - -
    - -
    1,307.92%
    Net Income, GAAP
    - -
    - -
    -76.94%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    0.14
    0.09
    0.1
    - -
    0.41
    2023
    0.03
    0.05
    -0.11
    - -
    0.13
    2024
    -0.09
    0.02
    - -
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business

    Company News

    • Churchill Capital Corp VII and CorpAcq Mutually Agree to Terminate Business Combination

    • Redemption Deadline for Churchill VII stockholders extended until August 9, 2024

    • CorpAcq and Churchill Capital Corp VII Provide an Update on Proposed Financing to Support Business Combination

    • /C O R R E C T I O N -- Churchill Capital Corp VII/

    • Special Meeting of Churchill VII Stockholders to Approve Business Combination with CorpAcq and Public Warrant Holder Meeting to Approve Warrant Amendment to be Adjourned and Reconvened for August 12, 2024

    • Special Meeting of Churchill Capital Corp VII Stockholders to Approve Business Combination with CorpAcq and Public Warrant Holder Meeting to Approve Warrant Amendment Scheduled for July 25, 2024

    • Reviewing Churchill Capital Corp VII (NYSE:CVII) and Blue Owl Capital Co. III (NYSE:OBDE)

    • Special Meeting of Churchill Capital Corp VII Stockholders to Approve Business Combination with CorpAcq and Warrant Holder Meeting to Approve Warrant Amendment Scheduled for May 21, 2024

    • Churchill Capital Corp VII Announces Stockholder Approval of Extension and Final Redemption Numbers

    • Churchill Capital Corp VII Announces Continuation of $1,000,000 Monthly Sponsor Contribution

    • Churchill Capital Corp VII Announces Intention to Transfer Listing to Nasdaq

    • CorpAcq Reaffirms 2023 Guidance and Provides Business and Refinancing Update

    • CorpAcq and Churchill Capital Corp VII Announce Filing of Registration Statement on Form F-4 in Connection with Proposed Business Combination and CorpAcq's First Half 2023 Results